Core Viewpoint - The company, Chongqing Taiji Industrial (Group) Co., Ltd., is selling idle real estate assets to optimize its asset structure and improve asset utilization, with a transaction price of 25.8498 million yuan [2][4]. Group 1: Transaction Overview - The company plans to sell an idle property located at No. 6, Xin Nan Road, Yubei District, Chongqing, through public listing [2][4]. - The transaction does not constitute a related party transaction or a major asset restructuring [3][4]. Group 2: Asset Details - The property has a building area of 820.63 square meters and a land use area of 1,951 square meters, with a registered purpose as a complete residential unit [5]. - The property is free from any mortgages, pledges, or third-party rights, and there are no significant disputes or judicial measures against it [5]. Group 3: Valuation and Pricing - The asset was appraised by Chongqing Huifeng Real Estate and Land Asset Appraisal Co., Ltd., with a market value of 25.8498 million yuan as of March 31, 2025 [6][7]. - The original book value of the asset was 9.3125 million yuan, with a net book value of 4.2785 million yuan, resulting in an appraisal increment of 21.5713 million yuan and an increase rate of 504.18% [8]. Group 4: Transaction Impact - The sale is expected to enhance the company's asset operation efficiency and will contribute approximately 18 million yuan to the company's financial results for 2025 [14].

Core Viewpoint - Taiji Group has received a loan commitment from China Merchants Bank's Chongqing branch for a stock repurchase program, indicating the company's strategic move to enhance shareholder value through buybacks [2] Group 1 - The loan commitment amount is up to 108 million yuan, which is not more than 90% of the actual amount used for the repurchase [2] - The financing term for the loan is set at 3 years [2] - The specific details of the loan will be formalized in a loan contract between the parties [2]

二、收到股份回购贷款承诺函的具体情况 近日，公司收到招商银行股份有限公司重庆分行出具的《贷款承 诺函》，主要内容如下： 证券代码：600129 证券简称：太极集团 公告编号：2025-061 重庆太极实业（集团）股份有限公司 关于取得金融机构股票回购贷款承诺函的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 一、本次回购股份方案的基本情况 重庆太极实业（集团）股份有限公司（以下简称"公司"）于 2025 年 7 月 16 日、8 月 6 日召开了第十届董事会第三十次会议、2025 年第二次临时股东大会，审议通过了<关于以集中竞价交易方式回购 公司股份预案>的议案。公司拟使用自有资金或自筹资金，通过集中 竞价交易方式回购公司人民币普通股 A 股，回购股份的资金总额为不 低于人民币8,000.00万元（含）且不超过人民币12,000.00万元（含）， 回购股份的价格为不超过 28.03 元/股（含），回购股份将全部用于 注销并减少公司注册资本，回购股份的实施期限为自公司股东大会审 议通过本次回购方案之日起 12 个月 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-060 重庆太极实业（集团）股份有限公司 关于出售闲置资产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 重要内容提示： 1.交易简要内容:重庆太极实业（集团）股份有限公司(以下简称： 公司)将公司位于重庆市渝北区新南路 6 号附 6 号 1 幢 1-1 闲置房产 通过公开挂牌方式出售，交易价格为 2,584.98 万元。 2.本次交易不构成关联交易 面积：建筑面积为 820.63 平方米，土地使用权面积为 1951 平方 米 证载用途：成套住宅 3.本次交易不构成重大资产重组 4.本次闲置房产已履行相关审批报备手续，无需提交董事会和公 司股东大会审议。 一、交易概述 为聚焦医药主业，盘活闲置资产，优化资产结构，提高公司资产 利用率，公司拟出售位于重庆市渝北区新南路 6 号附 6 号 1 幢 1-1 房 产。该事项已经公司总经理办公会审议通过，同意上述房产以评估价 值 2,584.98 万元在产权交易所对外公开挂牌出售。 根据《上海证券交易所股票上市 ...

Core Viewpoint - Taiji Group announced the sale of idle property in Chongqing for 25.8498 million yuan, aiming to enhance asset efficiency and align with business development needs [1] Summary by Relevant Sections Asset Sale - The company will sell an idle property located at No. 6, Xinnan Road, Yubei District, Chongqing through public listing [1] - The transaction price is set at 25.8498 million yuan [1] Financial Impact - The proceeds from the sale are expected to be approximately 18 million yuan, which will positively impact the company's financial status and operational performance [1] - The income from this asset disposal will be recorded in the company's 2025 financial results [1]

Group 1 - The company, Taiji Group (600129), announced on August 14 that it has received a loan commitment letter from China Merchants Bank's Chongqing branch, with a loan commitment amount not exceeding 108 million yuan [1] - The financing term for the loan is set at 3 years, and the purpose of the loan is designated for stock repurchase [1]

Core Viewpoint - Taiji Group (600129.SH) has acknowledged the recent notification from the National Health Commission and the National Administration of Traditional Chinese Medicine regarding the treatment plan for Chikungunya fever, highlighting the lack of specific treatment methods and the focus on symptomatic support [1] Group 1 - Chikungunya fever is an acute infectious disease caused by the Chikungunya virus, transmitted by mosquito bites, characterized by fever, joint pain, and rash [1] - Current treatment methods are primarily supportive, including fever reduction and physical cooling, with recommendations for using acetaminophen for persistent high fever [1] - The company’s subsidiary, Southwest Pharmaceutical Co., produces a medication called Sanlietong (generic name: Compound Acetaminophen Tablets II), which is suitable for alleviating fever caused by colds or flu, as well as various pain symptoms such as headaches, toothaches, and joint pain [1]

Summary of Key Points Core Viewpoint - On August 7, a total of 24 companies announced 25 stock repurchase updates, indicating a significant activity in stock buybacks within the market [1]. Group 1: Stock Repurchase Plans - Five companies disclosed stock repurchase plans for the first time, with two companies planning repurchases exceeding 10 million yuan. The highest proposed repurchase amounts are from Tapa Group at up to 100 million yuan, Maiwei Bio-U at 50 million yuan, and Yuhuan Numerical Control at 899,600 yuan [1]. - One company, Taiji Group, had its repurchase plan approved by the shareholders' meeting, with a proposed repurchase amount of up to 120 million yuan [1]. Group 2: Implementation Progress - Seven companies reported progress on their stock repurchase implementations, with Newland, Nanshan Aluminum, and Dazhong Mining having the highest repurchase amounts of 271 million yuan, 249 million yuan, and 177 million yuan, respectively [1]. Group 3: Completed Repurchases - Eleven companies have completed their stock repurchases, with five companies reporting amounts exceeding 10 million yuan. The highest completed repurchase amounts were from Dongfang Securities at 250 million yuan, Xusheng Group at 119 million yuan, and Beisimei at 53.2204 million yuan [1].

Group 1 - The stock price of Taiji Group closed at 23.81 yuan on August 6, 2025, down 1.41% from the previous trading day, with a trading volume of 554 million yuan [1] - Taiji Group operates in the traditional Chinese medicine sector, covering pharmaceutical manufacturing, pharmaceutical commerce, and the health industry, making it one of the important pharmaceutical companies in the western region [1] - The company held its second extraordinary general meeting of shareholders on August 6, 2025, where several proposals, including the change of accounting firm, were approved [1] Group 2 - On August 6, 2025, Taiji Group experienced a net outflow of 100 million yuan in main funds, with a cumulative net outflow of 99.33 million yuan over the past five days [1]

Meeting Details - The second extraordinary general meeting of shareholders was held on August 6, 2025, at the company's office in Chongqing [2] - The meeting was convened by the board of directors and chaired by Chairman Yu Min, complying with the Company Law and the company's articles of association [2][3] Resolutions Passed - The following resolutions were approved during the meeting: - Change of accounting firm [3] - Appointment of additional directors [3] - Abolishment of the supervisory board and amendment of the articles of association [3][4] - Amendments to corporate governance rules, including the rules for shareholder meetings, board meetings, and independent director work systems [4] - Share repurchase plan, including the purpose, amount, funding source, method, price, quantity, and authorization for the repurchase [4][5] Share Repurchase Plan - The company plans to repurchase shares using its own or self-raised funds, with a total amount between 80 million yuan and 120 million yuan, at a maximum price of 28.03 yuan per share [7] - The estimated number of shares to be repurchased is between 2,854,085 and 4,281,127, representing 0.51% to 0.77% of the total share capital [7] Legal Compliance - The meeting was witnessed by lawyers from Taihe Tai (Chongqing) Law Firm, confirming that the meeting's procedures and resolutions comply with legal requirements [5]